Can you provide the average price target for XENCOR INC stock?
20 analysts have analysed XNCR and the average price target is 27.97 USD. This implies a price increase of 124.8% is expected in the next year compared to the current price of 12.44.
NASDAQ:XNCR • US98401F1057
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XENCOR INC (XNCR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-24 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2026-02-26 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-29 | Barclays | Upgrade | Underweight -> Overweight |
| 2025-10-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-09-02 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-08-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-08-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-08 | Barclays | Maintains | Underweight -> Underweight |
| 2025-04-21 | William Blair | Initiate | Outperform |
| 2025-02-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-12 | Wells Fargo | Initiate | Overweight |
| 2024-12-02 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-11-08 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-06 | BMO Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 174.615M 6.08% | 110.493M -36.72% | 125.576M 13.65% | 121.06M -3.60% | 126.87M 4.80% | 172.7M 36.12% | 278.22M 61.10% | 538.66M 93.61% | 790.55M 46.76% | 1.116B 41.17% | 1.55B 38.89% | |
| EBITDA YoY % growth | -120.864M -63.99% | -166.301M -37.59% | -166.99M -0.41% | -163.287M 2.22% | -136.326M 16.51% | -201.557M -47.85% | -103.081M 48.86% | -108.905M -5.65% | 4.233M 103.89% | 91.239M 2,055.42% | 317.64M 248.14% | |
| EBIT YoY % growth | -132.362M -60.44% | -178.408M -34.79% | -177.502M 0.51% | -236.343M -33.15% | -266.906M -12.93% | -272.97M -2.27% | -166.906M 38.86% | -37.306M 77.65% | 145.17M 489.14% | 375.55M 158.70% | 685.18M 82.45% | |
| Operating Margin | -75.80% | -161.47% | -141.35% | -195.23% | -210.38% | -158.06% | -59.99% | -6.93% | 18.36% | 33.65% | 44.21% | |
| EPS YoY % growth | -2.10 -125.81% | -3.51 -67.14% | -1.24 64.67% | -2.72 -119.34% | -2.65 2.69% | -2.57 3.08% | -1.88 26.84% | 0.03 101.40% | 1.44 5,399.22% | 3.28 127.41% | 5.67 73.06% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.77 -17.11% | -0.78 -90.64% | -0.78 -878.56% | -0.82 -814.71% | -0.88 -13.83% | -0.91 -16.40% | -0.88 -12.73% | -0.83 -0.33% | -0.95 -7.81% | -0.97 -6.50% | -0.95 -7.49% | -0.96 -16.08% |
| Revenue Q2Q % growth | 27.942M -14.63% | 31.051M -28.80% | 32.632M 55.40% | 33.071M 17.12% | 18.248M -34.69% | 18.94M -39.00% | 20.07M -38.50% | 20.918M -36.75% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -52.53M -29.74% | -56.61M -103.44% | -53.55M -35.28% | -56.1M -30.11% | -33.66M 35.92% | -33.66M 40.54% | -33.66M 37.14% | -33.66M 40.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -53.392M -23.64% | -53.798M -62.18% | -55.807M -17.44% | -62.263M -16.10% | -69.87M -30.86% | -72.42M -34.61% | -72.93M -30.68% | -75.48M -21.23% | N/A | N/A | N/A | N/A |
All data in USD
20 analysts have analysed XNCR and the average price target is 27.97 USD. This implies a price increase of 124.8% is expected in the next year compared to the current price of 12.44.
XENCOR INC (XNCR) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of XENCOR INC (XNCR) is -0.77 USD and the consensus revenue estimate is 27.94M USD.
The number of analysts covering XENCOR INC (XNCR) is 20.